Published
Zolbetuximab temperature excursion/extended stability for unopened 100 mg and 300 mg vials: 3 days at 40°C, 6 days at 30°C, 14 days at 25°C and 7 days at -20°C

During shipping/storage, three temperature excursions are allowed in total, across any of the listed temperature conditions.1

The stability of single-dose zolbetuximab vials was evaluated under thermal cycling, stress, and accelerated conditions.1 No impact on quality was observed from all three tests for both 100 mg and 300 mg vials.

  • In thermal cycling, vials were stored at 40°C for 2 hours then at -20°C for 2 hours, repeated three times.
  • Under stress, vials were stored at -20°C for 1 month and at 40°C for 3 months.
  • For the accelerated condition, vials were stored at 25°C for 6 months. 

Table 1. Allowable temperature excursion range during shipping/storage for zolbetuximab 1

Strength

Formulation

Package configuration

Allowable temperature excursion

Allowable temperature excursion

High sidea

Low sidea

100 mg

Global (single)

Vial

40°C for 3 days

30°C for 6 days

25°C for 14 days

-20°C for 7 days

300 mg

Global (single)

Vial

40°C for 3 days

30°C for 6 days

25°C for 14 days

-20°C for 7 days

a Three temperature excursions are allowed in total.

  1. Data on File.

If you are not able to find the information through the Search function, please contact our Medical Communications and Engagement Department by using any of the channels below:

Connect with Field Medical

Connect with Field Medical

Medical Science Liaisons (MSLs) and Medical Value and Access (MV&A) team members are available to help answer your scientific and health economic questions.

 

Submit an Inquiry

Submit an Inquiry

For any medical inquiries, please submit your question online to Astellas Medical Information or call or fax your inquiry.

Astellas Phone: 1-800-727-7003

Fax: 1-877-829-7942

Hours: M–F, 8 AM–4:30 PM (CT)

Report an Adverse Event or Product Complaint

Report an Adverse Event or Product Complaint

Report adverse events and product complaints to Astellas or FDA MedWatch.

Astellas Phone: 1-800-727-7003

FDA MedWatch: 1-800-FDA-1088

Hours: M–F, 8 AM–4:30 PM (CT)